News · Subject area

Investment & Markets

One verified story each weekday, The MedTwenty Brief on Fridays and a monthly analysis. Every fact is checked against its primary source.

All subjects NHS & Healthcare Finance Healthcare Companies Healthcare Technology Regulation & Policy Investment & Markets

Everything Stories The Brief Analysis

All regions UK US Global

Two architectural models placed side by side on stone

Investment & Markets

Tempus acquires Personalis in $1.5bn deal, deepening push into cancer genomics

The AI-diagnostics firm absorbs its oncology genomics partner three years after their initial collaboration — and sets up a direct contest with Foundation Medicine for NHS pathology contracts. Full deal terms, adviser detail and competitive landscape analysis in the intelligence database.

LiveOruaro Onibere·4 min read·27 Sept 2026, 08:18

A chess king standing beside a fallen pawn on stone

Investment & Markets

KKR completes Envision restructuring at $7.0bn, wiping out earlier equity

The restructuring closes one of the largest loss-making healthcare buyouts of the last decade.

PremiumM. Chen·6 min read·25 Sept 2026, 08:30

A fountain pen resting on a blank contract

Investment & Markets

Optum closes $3.2bn Landmark acquisition, extending home-based care reach

The transaction completes after a nine-month regulatory review.

M. Chen·4 min read·24 Sept 2026, 08:30

An empty glass atrium with a stone bench at golden hour

Investment & Markets

Japan opens reimbursement pathway for digital therapeutics

A new category creates the first predictable route to national reimbursement.

R. Okonkwo·4 min read·20 Sept 2026, 08:30

Investment & Markets

Precision Diagnostics Fund Exceeds Target with £150m Close for Next-Gen Diagnostic Technologies

Precision Diagnostics Fund (PDF) has announced the final close of its inaugural fund, securing £150 million, significantly surpassing its initial £100 million target. The oversubscribed fund will primarily invest in European and UK-based start-ups developing innovative diagnostic technologies, from advanced imaging to liquid biopsies.

PremiumOruaro Onibere·7 min read·8 Sept 2026, 09:00

Investment & Markets

New 'Frontier Health Fund' Launched with $500m to Back Innovation in Developing Markets

A consortium of institutional investors and development banks has inaugurated the 'Frontier Health Fund,' a $500 million vehicle aimed at catalysing healthcare innovation in emerging and frontier markets. The fund targets solutions for neglected diseases and health system strengthening.

James Whitfield·7 min read·8 Sept 2026, 09:00

Investment & Markets

MKTG Holdings Acquires Global Health Data Analytics Firm for $1.2bn, Eyeing Emerging Markets

MKTG Holdings, a diversified investment conglomerate, has completed its acquisition of Global Health Data Analytics (GHDA) for an estimated $1.2 billion. The deal positions MKTG for significant expansion into rapidly growing healthcare markets in Asia and Africa.

S. Adeyemi·7 min read·6 Sept 2026, 09:00

Investment & Markets

Syngene International Acquires Novartis's UK Research Hub in £280m Deal, Bolstering Global R&D Footprint

Indian contract research giant Syngene International has announced the acquisition of Novartis's prominent UK-based drug discovery and development facility for £280 million. The strategic move aims to significantly expand Syngene's capabilities in early-stage research and access a skilled European scientific workforce.

S. Adeyemi·7 min read·2 Sept 2026, 09:00

Investment & Markets

Private Equity Firms Drive Biotech M&A Surge, Focusing on Strategic Repositioning

Private equity (PE) firms are increasingly active in the biotech M&A landscape, moving beyond traditional buyouts to strategic repositioning of assets. This trend is reshaping the competitive dynamics of the pharmaceutical industry.

Oruaro Onibere·7 min read·25 Aug 2026, 09:00

Showing 1–9 of 9 pieces